We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bio-Techne
TECH
$11.3B
| $23.4M | 0.09% |
292,748
-41,000
| -12% | -$3.08M |
|
202
Standex International
SXI
$4.02B
| $23.3M | 0.09% |
127,700
+5,000
| +4% | +$869K |
|
203
Royal Caribbean
RCL
$82.9B
| $23.3M | 0.09% |
131,112
+1,946
| +2% | +$315K |
|
204
Aflac
AFL
$60.7B
| $23.1M | 0.09% |
206,771
+39,815
| +24% | +$4.05M |
|
205
Palomar
PLMR
$3.35B
| $22.7M | 0.09% |
239,267
+1,000
| +0.4% | +$92.1K |
|
206
PNC Financial Services
PNC
$102B
| $22.6M | 0.09% |
121,997
-8,779
| -7% | -$1.54M |
|
207
Newmont
NEM
$120B
| $22.5M | 0.09% |
421,747
+17,070
| +4% | +$848K |
|
208
Sysco
SYY
$40.3B
| $22.3M | 0.09% |
285,695
+10,530
| +4% | +$792K |
|
209
BlackLine
BL
$1.67B
| $22.3M | 0.09% |
404,400
+116,900
| +41% | +$5.76M |
|
210
Fastenal
FAST
$58.9B
| $22.2M | 0.09% |
621,926
+5,922
| +1% | +$200K |
|
211
Cintas
CTAS
$80.6B
| $21.9M | 0.09% |
106,322
+17,998
| +20% | +$3.47M |
|
212
Marvell Technology
MRVL
$205B
| $21.9M | 0.09% |
303,119
+3,930
| +1% | +$271K |
|
213
Gates Industrial Corporation Ltd.
GTES
$7.04B
| $21.8M | 0.09% |
1,242,600
+69,200
| +6% | +$1.18M |
|
214
General Mills
GIS
$20.6B
| $21.8M | 0.09% |
295,170
-3,141
| -1% | -$218K |
|
215
CRH
CRH
$66B
| $21.8M | 0.09% |
235,005
-17,928
| -7% | -$1.51M |
|
216
Verisk Analytics
VRSK
$23.4B
| $21.7M | 0.09% |
81,033
+1,672
| +2% | +$453K |
|
217
Coupang
CPNG
$29B
| $21.7M | 0.09% |
884,144
+24,553
| +3% | +$546K |
|
218
CrowdStrike
CRWD
$229B
| $21.7M | 0.09% |
308,992
-20,424
| -6% | -$1.45M |
|
219
Zimmer Biomet
ZBH
$18.7B
| $21.6M | 0.09% |
200,269
-107,194
| -35% | -$11.7M |
|
220
eBay
EBAY
$46.1B
| $21.1M | 0.08% |
324,082
+1,334
| +0.4% | +$76.8K |
|
221
Old Dominion Freight Line
ODFL
$45B
| $21M | 0.08% |
105,772
+1,380
| +1% | +$268K |
|
222
Keurig Dr Pepper
KDP
$41.9B
| $20.9M | 0.08% |
558,944
-3,372
| -0.6% | -$119K |
|
223
Essential Properties Realty Trust
EPRT
$6.69B
| $20.6M | 0.08% |
603,500
+569,400
| +1,670% | +$17.6M |
|
224
D.R. Horton
DHI
$41.6B
| $20.6M | 0.08% |
107,786
+5,243
| +5% | +$921K |
|
225
Ferguson
FERG
$48B
| $20.4M | 0.08% |
102,948
+2,376
| +2% | +$481K |
|
Similar funds
VIA
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.